BRIEF published on 04/04/2025 at 11:21, 1 year 5 months ago Vester Finance réduit sa participation dans ADOCIA Droits De Vote Franchissement De Seuil Actions ADOCIA Vester Finance
PRESS RELEASE published on 04/04/2025 at 11:16, 1 year 5 months ago Franchissement de seuil Déclaration de franchissement de seuil par Vester Finance pour 9,82% du capital de ADOCIA Franchissement De Seuil Marché ADOCIA Vester Finance 10%
BRIEF published on 02/28/2025 at 19:33, 1 year 6 months ago Adocia finalise un placement privé de 9,7 millions d'euros Capital Social Placement Privé Biopharmaceutique Traitement Du Diabète ADOCIA
BRIEF published on 02/28/2025 at 19:33, 1 year 6 months ago Adocia Completes €9.7 Million Private Placement Private Placement Share Capital Biopharmaceutical Diabetes Treatment ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year 6 months ago Informations privilégiées / Autres communiqués Adocia annonce le règlement-livraison de son placement privé de 9,7 millions d'euros, avec émission d'actions nouvelles et bons de souscription d'actions Placement Privé Biopharmaceutique Actions Nouvelles Bons De Souscription ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year 6 months ago Inside Information / Other news releases Adocia successfully settles and delivers €9.7 million private placement, issuing 2,125,000 new ordinary shares with warrants. Admittance to trading on Euronext Paris confirmed Private Placement Euronext Paris Diabetes Biopharmaceutical ADOCIA
BRIEF published on 02/26/2025 at 08:47, 1 year 6 months ago ADOCIA strengthens its cash flow with a private placement of 9.7 million euros Private Placement Capital Increase Biopharmaceutical Third Party Capital Financial Tonnage
BRIEF published on 02/26/2025 at 08:47, 1 year 6 months ago ADOCIA renforce sa trésorerie par un placement privé de 9,7 millions d'euros Placement Privé Augmentation De Capital Biopharmaceutique Tiers De Capital Tonnage Financier
PRESS RELEASE published on 02/26/2025 at 08:42, 1 year 6 months ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Adocia annonce un placement privé de 9,7 millions d'euros, prolongeant sa trésorerie jusqu'au 2ème trimestre 2026. Augmentation de capital et financement de projets biopharmaceutiques Placement Privé Augmentation De Capital Biopharmaceutique Trésorerie ADOCIA
PRESS RELEASE published on 02/26/2025 at 08:42, 1 year 6 months ago Inside Information / Operations of the issuer (acquisitions, sales...) Adocia successfully completes €9.7 million private placement, extending cash runway to Q2 2026. New shares issued with warrants attached. Notable investors include Gerard Soula and Armistice Capital Private Placement Investors New Shares Cash Runway ADOCIA
Published on 09/12/2026 at 02:35, 11 hours 13 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 48 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 43 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 23 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 48 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 18 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 33 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 38 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 3 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 33 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
